Pharmacokinetic Study of Two Oral Bemiparin Formulations.

Trial Profile

Pharmacokinetic Study of Two Oral Bemiparin Formulations.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Mar 2011

At a glance

  • Drugs Bemiparin sodium (Primary)
  • Indications Catheter thrombosis; Deep vein thrombosis; Diabetic foot ulcer; Thromboembolism
  • Focus Pharmacokinetics
  • Most Recent Events

    • 16 Mar 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 16 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 May 2010 Planned end date changed from 1 Nov 2009 to 1 Nov 2010 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top